These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7456427)

  • 1. [Polysaccharide complex of human ovarian cancer studied by the microprecipitation reaction].
    Gorodilova VV; Ul'chenko VM
    Vopr Onkol; 1980; 26(11):62-5. PubMed ID: 7456427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum and tissue measurements of CA72-4 in ovarian cancer patients.
    Negishi Y; Iwabuchi H; Sakunaga H; Sakamoto M; Okabe K; Sato H; Asano G
    Gynecol Oncol; 1993 Feb; 48(2):148-54. PubMed ID: 8381375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor markers in ovarian cancer: tumor-associated antigens.
    Barlow JJ; Bhattacharya M
    Semin Oncol; 1975 Sep; 2(3):203-9. PubMed ID: 827023
    [No Abstract]   [Full Text] [Related]  

  • 4. Tumor marker in ovarian cancer. Tumor-associated antigen.
    Barlow JJ; Bhattacharya M
    N Y State J Med; 1977 Mar; 77(3):342-3. PubMed ID: 265013
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antigenic specificity of the polysaccharide fraction of ovarian adenocarcinoma in the delayed hypersensitivity reaction].
    Ul'chenko VM; Gorodilova VV; Bashkaev IS
    Vopr Onkol; 1976; 22(3):3-7. PubMed ID: 936525
    [No Abstract]   [Full Text] [Related]  

  • 6. Tumour-associated antigens for cystadenocarcinoma of the ovary.
    Barlow JJ; Bhattacharya M
    Clin Obstet Gynaecol; 1983 Aug; 10(2):187-96. PubMed ID: 6413113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of human ovarian tumor-associated antigens by antibodies isolated from ovarian carcinoma ascitic fluid.
    Rao GS; Hanjani P
    Am J Obstet Gynecol; 1988 Jul; 159(1):94-8. PubMed ID: 3394756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterophile antigens in serous cystadenocarcinoma of the human ovary.
    Kamada M; Mori T; Sakamoto Y; Daitoh T; Furumoto H; Irahara M; Aono T; Mori T
    Asia Oceania J Obstet Gynaecol; 1992 Dec; 18(4):387-95. PubMed ID: 1283511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preparation and characterization of a monoclonal antibody reactive with human ovarian serous cystadenocarcinoma].
    Ookura N
    Nihon Gan Chiryo Gakkai Shi; 1987 Feb; 22(1):47-58. PubMed ID: 2440966
    [No Abstract]   [Full Text] [Related]  

  • 10. Leukocyte migration in ovarian carcinoma: comparison of inhibitory activity of tumor extracts.
    Faiferman I; Gleicher N; Cohen CJ; Koffler D
    J Natl Cancer Inst; 1977 Dec; 59(6):1593-7. PubMed ID: 200754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian tumor antigens: preliminary histological investigation.
    Daunter B; Jaa-Kwee D; Miklosi S; Wright G
    Gynecol Oncol; 1986 Mar; 23(3):364-70. PubMed ID: 3514391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An immunologic comparison between serous cystadenocarcinoma of the ovary and other human gynecologic tumors.
    Bhattacharya M; Barlow JJ
    Am J Obstet Gynecol; 1973 Nov; 117(6):849-53. PubMed ID: 4126800
    [No Abstract]   [Full Text] [Related]  

  • 13. [Study of humoral and cellular immunity in the course of ovarian carcinoma].
    Laghi V; Carella G; Burrai I; Sacco F; Margariti PA; Villani L; Benedetti Panici P
    Minerva Ginecol; 1979 Oct; 31(10):737-46. PubMed ID: 317512
    [No Abstract]   [Full Text] [Related]  

  • 14. Glycoprotein detection using the periodic acid/Schiff reagent: a microassay using microtitration plates.
    Devine PL; Warren JA; Layton GT
    Biotechniques; 1990 Apr; 8(4):354-6. PubMed ID: 2340167
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunodiagnosis of ovarian cancer].
    Zhang J; Cao Z; Sun Z; Sun Z
    Hua Xi Yi Ke Da Xue Xue Bao; 1991 Sep; 22(3):325-8. PubMed ID: 1748422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of tumor-specific antigens in human mucinous cystadenocarcinoma of the ovary by immunodiffusion.
    Chow SN; Chiang WT; Wei PY
    Int J Gynaecol Obstet; 1976; 14(3):280-4. PubMed ID: 13019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-specificity of the tumour marker CA 19-9: a case of ovarian carcinoma with recurrent venous thrombosis.
    Smellie S; Lambert M
    Acta Gastroenterol Belg; 1987; 50(2):241-2. PubMed ID: 3481507
    [No Abstract]   [Full Text] [Related]  

  • 18. [Circulating immune complex of ovarian epithelial carcinoma and its clinical use].
    Cui H; Qian HN
    Zhonghua Fu Chan Ke Za Zhi; 1987 Jul; 22(4):223-5, 253-4. PubMed ID: 3665670
    [No Abstract]   [Full Text] [Related]  

  • 19. [Sharing antigenic determinant of colon carcinoma between serous and mucinous tumors of the ovary].
    Liu MP; Lu ZT; Chen W
    Zhonghua Fu Chan Ke Za Zhi; 1994 Jul; 29(7):398-400, 444. PubMed ID: 7528120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunologic studies of human serous cystadenocarcinoma of ovary. Demonstration of tumor-associated antigens.
    Bhattacharya M; Barlow JJ
    Cancer; 1973 Mar; 31(3):588-95. PubMed ID: 4632680
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.